Visualitza per autor "IACOBONI, GLORIA"
Ara mostrant els elements 1-11 d 11
-
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality
Hansen, Doris; Bachy, Emmanuel; bansal, radhika; Rejeski, Kai; Wang, Yucai; IACOBONI, GLORIA; Barba, Pere (American Society of Hematology, 2024-04-23) -
Case report: Cytokine hemoadsorption in a case of hemophagocytic lymphohistiocytosis secondary to extranodal NK/T-cell lymphoma
Ruiz-Rodriguez, Juan Carlos; Chiscano Camon, Luis; Ruiz Sanmartin, Adolfo; Palmada Ibars, Clara; Bajaña Mindiolaza, Ivan Rene; Bonilla Rojas, Camilo Andres; García Roche, Alejandra; Plata Menchaca, Erika Paola; Maldonado Toral, Carolina; Martínez Gallo, Mónica; Franco-Jarava, Clara; Hernandez-Gonzalez, Manuel; Ferrer, Ricard; IACOBONI, GLORIA; Pérez Carrasco, Marcos (Frontiers Media, 2022-08-15) -
Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
Busch, Galina; Baumann, Stephan; Jitschin, Regina; Iraola, Josu; Blumenberg , Viktoria; IACOBONI, GLORIA; Gallur, Laura; Barba, Pere (The American Society of Hematology, 2023-11-28) -
From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia
Bosch-Schips, Jan; Serna, Angel; Abrisqueta, Pau; Nadeu, Ferran; IACOBONI, GLORIA; Cabirta, Alba; Bosch, Francesc (Elsevier, 2023-11) -
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
Perez, Ariel; Jurinovic, Vindi; Holtick, Udo; Rejeski, Kai; IACOBONI, GLORIA; Bücklein, Veit (Wolters Kluwer Health, 2023-07-11) -
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY
Minga, Eva; Chamou, Dimitra; Chatzikonstantinou, Thomas; Scarfo', Lydia; KARAKATSOULIS, GEORGIOS; IACOBONI, GLORIA (Elsevier, 2023-11) -
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
IACOBONI, GLORIA; Rejeski, Kai; Villacampa Javierre, Guillermo; van Doesum, Jaap; CHIAPPELLA, ANNALISA; Bonifazi, Francesca; Camacho-Arteaga, Lina ; Marin Niebla, Ana; Barba, Pere (American Society of Hematology, 2022-06-28) -
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
Burchert, Andreas; SESQUES, Pierre; Fransecky, Lars; Rejeski, Kai; IACOBONI, GLORIA; Barba, Pere; Bücklein, Veit (American Society of Hematology, 2022-08-23) -
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
Perez, Ariel; Blumenberg , Viktoria; Bücklein, Veit; Völkl, Simon; Rejeski, Kai; IACOBONI, GLORIA; Barba, Pere (American Association for the Advancement of Science, 2023-09-22) -
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL
Wang, Yucai; albanyan, omar; Munoz, Javier; Rejeski, Kai; SESQUES, Pierre; IACOBONI, GLORIA; Barba, Pere (Wiley, 2023-11) -
Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies
León-Román, Juan; Bolufer Cardona, Monica; Sánchez-Salinas, Mario; Alonso-Martínez, Carla; Bestard, Oriol; IACOBONI, GLORIA; Bermejo García, Sheila; Cecilia del Carmen, Carpio Segura; Garcia-Carro, Clara; Barba, Pere; Soler, María José (Oxford University Press, 2024-03)